Skip to main content

Table 4 Analysis of fibrosis on OS and DSS stratified by TNM stage and therapy

From: Does fibrosis have an impact on survival of patients with hepatocellular carcinoma: evidence from the SEER database?

TNM Stage

Therapy

Overall Survival

Disease-specific Survival

HR (95%CI)

P Value

HR (95%CI)

P Value

I + II

No

1.03(0.91–1.17)

0.612

0.98(0.85–1.12)

0.756

Yes

1.11(0.98–1.27)

0.098

1.08(0.93–1.26)

0.302

III + IV

No

1.09(0.99–1.20)

0.085

1.07(0.97–1.19)

0.178

Yes

1.08(0.85–1.38)

0.541

1.01(0.78–1.31)

0.956